HU-045
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HU-045, covering 2023-07-05 to 2024-10-03. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III) [Phase 3]